enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Hyperammonemia - Wikipedia

   en.wikipedia.org/wiki/Hyperammonemia

   Treatment of severe hyperammonemia (serum ammonia levels greater than 1000 μmol/L) should begin with hemodialysis if it is otherwise medically appropriate and tolerated. [ 12 ] Continuous renal replacement therapy (CRRT) is a remarkably effective mode of therapy in neonatal hyperammonemia, particularly in severe cases of Urea cycle defects ...

3. Hepatic encephalopathy - Wikipedia

   en.wikipedia.org/wiki/Hepatic_encephalopathy

   [2] [6] It may be supported by blood ammonia levels, an electroencephalogram, or computer tomography (CT scan) of the brain. [4] [6] Hepatic encephalopathy is possibly reversible with treatment. [1] This typically involves supportive care and addressing the triggers of the event. [4] Lactulose is frequently used to decrease ammonia levels. [1]

4. Cirrhosis - Wikipedia

   en.wikipedia.org/wiki/Cirrhosis

   Ammonia is normally metabolized by the liver; as cirrhosis causes both decreased liver function and increased portosystemic shunting (allowing blood to bypass the liver), systemic ammonia levels gradually rise and lead to encephalopathy. [137] Most pharmaceutical approaches to treating hepatic encephalopathy focus on reducing ammonia levels. [138]

5. Fatty Liver Disease: What Men Need to Know - AOL

   www.aol.com/fatty-liver-disease-men-know...

   Dyslipidemia (abnormal levels of lipids, or fats, in your blood) Prostock-Studio / iStock. ... For alcoholic liver disease, treatment will include cutting out alcohol. You can do this by:

6. Ornithine transcarbamylase deficiency - Wikipedia

   en.wikipedia.org/wiki/Ornithine_transcarbamylase...

   If a hyperammonemic episode occurs, the aim of treatment is to reduce the individual's ammonia levels as soon as possible. In extreme cases, this can involve hemodialysis. [4] Gene therapy had been considered a possibility for curative treatment for OTC deficiency, and clinical trials were taking place at the University of Pennsylvania in the ...

7. Gilead gets US FDA approval for inflammatory liver disease drug

   www.aol.com/news/us-fda-approves-gileads-liver...

   The disease, primary biliary cholangitis (PBC), causes inflammation of the small bile ducts in the liver and can eventually destroy them. Rival drug, Iqirvo, from Ipsen costs $11,500 per month.